Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Alzheimer'S & Dementia (New York, N. Y.)|May 22, 2023
Open drug discovery in Alzheimer's diseaseAlison D Axtman, Paul E Brennan, Tristan Frappier-Brinton, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Structure-activity Relationship for Diarylpyrazoles as Inhibitors of the Fungal Kinase Yck2David J Shirley, Bonnie Yiu, Ikeer Mancera-Ortiz, et al.
Frontiers in Chemical Biology|April 20, 2026
Development of SYK NanoBRET cellular target engagement assays for gain-of-function variantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Scientific Reports|August 2, 2020
Synergistic drug combinations and machine learning for drug repurposing in chordomaEdward Anderson, Tammy M Havener, Kimberley M Zorn, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function VariantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentKarina Leal, Elizabeth L Zoeller, Gregory A Cary, et al.
Chemmedchem|April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor ChemotypeChristopher R M Asquith, Louisa Temme, Michael P East, et al.
ACS Chemical Biology|June 10, 2015
Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon GrowthHassan Al-Ali, Do-Hun Lee, Matt C Danzi, et al.
Journal of Medicinal Chemistry|April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in ChordomaChristopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Pageof 16